GoHealth (NASDAQ:GOCO) Trading 1.8% Higher – Should You Buy?

GoHealth, Inc. (NASDAQ:GOCOGet Free Report) traded up 1.8% on Thursday . The stock traded as high as $11.58 and last traded at $11.50. 17,180 shares were traded during trading, a decline of 9% from the average session volume of 18,867 shares. The stock had previously closed at $11.30.

Analyst Upgrades and Downgrades

Separately, Royal Bank of Canada reaffirmed a “sector perform” rating and set a $13.00 price objective on shares of GoHealth in a report on Monday, October 21st.

Read Our Latest Stock Analysis on GOCO

GoHealth Trading Up 1.8 %

The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 1.72. The company’s fifty day moving average price is $10.56 and its two-hundred day moving average price is $10.21. The company has a market cap of $263.47 million, a price-to-earnings ratio of -3.29 and a beta of 1.66.

Institutional Trading of GoHealth

Several hedge funds have recently modified their holdings of GOCO. Vanguard Group Inc. grew its stake in shares of GoHealth by 2.8% during the first quarter. Vanguard Group Inc. now owns 206,525 shares of the company’s stock valued at $2,171,000 after purchasing an additional 5,605 shares during the last quarter. Bank of New York Mellon Corp grew its stake in shares of GoHealth by 16.1% during the second quarter. Bank of New York Mellon Corp now owns 12,982 shares of the company’s stock valued at $126,000 after purchasing an additional 1,802 shares during the last quarter. Renaissance Technologies LLC grew its stake in shares of GoHealth by 22.0% during the second quarter. Renaissance Technologies LLC now owns 18,272 shares of the company’s stock valued at $178,000 after purchasing an additional 3,300 shares during the last quarter. Empowered Funds LLC grew its stake in shares of GoHealth by 5.1% during the third quarter. Empowered Funds LLC now owns 22,048 shares of the company’s stock valued at $207,000 after purchasing an additional 1,072 shares during the last quarter. Finally, Barclays PLC grew its stake in shares of GoHealth by 83.9% during the third quarter. Barclays PLC now owns 9,580 shares of the company’s stock valued at $89,000 after purchasing an additional 4,372 shares during the last quarter. 24.21% of the stock is owned by institutional investors.

GoHealth Company Profile

(Get Free Report)

GoHealth, Inc operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs.

Recommended Stories

Receive News & Ratings for GoHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GoHealth and related companies with MarketBeat.com's FREE daily email newsletter.